Clinical Trials Directory

Trials / Completed

CompletedNCT03821714

Effects of Glucocorticoid Combined With Vitamin C and Vitamin B1 on Microcirculation in Severe Septic Shock

Effects of Glucocorticoid Combined With Vitamin C and Vitamin B1 Versus Hydrocortisone Alone on Microcirculation in Severe Septic Shock

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aimed to investigate the effect of Glucocorticoid combined with vitamin C and vitamin B1 versus hydrocortisone alone on microcirculation in septic shock patients.

Detailed description

This prospective, double-blind, randomized, controlled trial enrolled septic shock patients admitted to the intensive care unite of a tertiary teaching hospital. We randomly assigned the enrolled patients to the treatment group (hydrocortisone combined with vitamin C and vitamin B1 added to standard care) and the control group (hydrocortisone alone added to standard care) in a 1:1 ratio. The primary outcome was perfusion vascular density (PVD) at 24 hours after treatment. We used the sublingual microcirculation imaging system to monitor PVD. We further validated the primary outcome by observing differences in renal perfusion monitored by renal contrast-enhanced ultrasound (CEUS) between the treatment group and the control group.

Conditions

Interventions

TypeNameDescription
DRUGGlucocorticoid combination therapyGlucocorticoid combination therapy is defined as the combination of hydrocortisone, vitamin C, and vitamin B1.
DRUGGlucocorticoidThe glucocorticoid group was defined as the use of hydrocortisone alone.

Timeline

Start date
2019-02-01
Primary completion
2020-01-01
Completion
2020-01-30
First posted
2019-01-30
Last updated
2023-10-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03821714. Inclusion in this directory is not an endorsement.